Viewing Study NCT00085904


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2025-12-29 @ 2:50 AM
Study NCT ID: NCT00085904
Status: COMPLETED
Last Update Posted: 2008-10-13
First Post: 2004-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module